BlackRock Health Sciences Trust
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q4 24 | Q2 25 | Q4 25 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -34.8% | +1,412.2% | -6.9% | +38.4% | -119.4% | – | -175.6% | – | +431.1% | -285.4% | – | |
| – | – | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | +100.0% | +753.4% | +100.0% | -167.4% | – | – | +100.0% | -156.4% | – | -133.0% | – | |
| – | – | – | – | -100.0% | – | -100.0% | – | +66.7% | -100.0% | – | -100.0% | |
| – | – | – | – | – | – | – | – | +312.9% | -52.9% | -51.8% | – | |
| – | +100.0% | -48.6% | +100.0% | -47.4% | +100.0% | -51.0% | +100.0% | +3.6% | +11.0% | +0.1% | – | |
| – | +0.0% | -79.5% | +0.0% | – | – | – | – | – | -52.7% | – | – | |
| – | – | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | +100.0% | +388.6% | +100.0% | -35.6% | +100.0% | -50.9% | +100.0% | +170.0% | -28.3% | -40.7% | – | |
| – | – | – | – | – | – | – | +99.7% | +711.4% | +579.3% | -216.5% | – | |
| – | -34.8% | +1,412.2% | -6.9% | +38.4% | -119.4% | – | -175.6% | – | +3,475.5% | -127.5% | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.